Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP
Published Date: 1/29/2026
Proposed Rule
Summary
The government wants your thoughts on updating rules that stop sneaky deals and freebies in Medicare and state health programs, especially for new drug sales like those on TrumpRx. This could change how drug companies sell directly to patients, making meds fairer and cheaper for Americans. Speak up by March 30, 2026, to help shape these important changes that could save money and protect patients.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
TrumpRx: Direct-to-Consumer Drug Platform
HHS is establishing TrumpRx, a platform to let American patients buy prescription drugs directly from manufacturers at a “Most‑Favored‑Nation” price, bypassing middlemen. HHS says removing government obstacles to ensure access to affordable prescription drugs through TrumpRx is a key priority and is seeking public input through this request for information.
Potential Changes to Anti‑Kickback Safe Harbors
The OIG is asking whether to modify or add safe harbors to the Federal anti‑kickback statute (42 CFR 1001.952) and exceptions to the Beneficiary Inducements CMP (42 CFR 1003.110) to support direct‑to‑consumer manufacturer drug sales while protecting against fraud and abuse. The agency requests public comment by March 30, 2026.
Safe Harbor for Personal Services/Management Contracts
The RFI notes that existing safe harbors relevant to direct‑to‑consumer programs may include the personal services and management contracts safe harbor (42 CFR 1001.952(d)) and asks for input on conditions that should be included in any new or modified safe harbor.
Guidance vs Regulation for DTC Sales
OIG is asking whether clarifying guidance (for example, an amended Special Advisory Bulletin, FAQs, or other guidance) might be sufficient instead of new regulations to address direct‑to‑consumer sales to people covered by Federal health care programs. The RFI seeks examples and feedback and sets a comment deadline of March 30, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-05676 — Administrative Simplification; Adoption of Standards for Health Care Claims Attachments Transactions and Electronic Signatures
Starting May 26, 2026, health care providers, insurers, and tech companies must use new electronic standards for sending extra info with health care claims and for electronic signatures. This change makes claim processing faster and less paper-heavy, with full compliance required by May 26, 2028. It’s a big step toward smoother, quicker health care paperwork that saves time and money!
2026-04797 — Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction
This document fixes some typos and technical mistakes in the Medicare and Medicaid payment rules for 2026. It affects doctors, healthcare providers, and anyone using Medicare Part B by clarifying payment policies and program requirements starting January 1, 2026. These corrections help make sure payments and coverage rules are clear and accurate, so everyone gets paid right and on time.
2026-04467 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some missing labels in important tables from the 2027 health insurance rules under the Affordable Care Act. It mainly affects insurance companies and people using marketplace plans by clarifying how risk and payments are calculated. These fixes take effect right away on March 6, 2026, ensuring everyone has clear info before the 2027 plan year starts.
2025-23081 — Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program; Correction
This correction fixes some math and typo mistakes in the Medicare payment rules for inpatient rehab facilities starting October 1, 2025. It mainly affects rehab centers by updating their payment rates and quality reporting details to be fair and accurate. These changes ensure providers get the right money and info for the 2026 fiscal year.
2025-22543 — Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model
Medicare is updating its payment plans to help more people get organ transplants through the Increasing Organ Transplant Access (IOTA) Model starting in Performance Year 2. These changes affect hospitals and doctors who work with Medicare patients needing transplants, aiming to improve care and save lives. Comments on the proposed rule are open until February 9, 2026, so stakeholders can share their thoughts before it’s finalized.
2025-21767 — Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies
Starting in 2026, Medicare is updating how it pays for home health care and durable medical equipment, making sure payments match patient needs better. Home health providers will see new rules for quality reporting and value-based programs, while suppliers must meet updated accreditation and enrollment standards. These changes affect patients, providers, and suppliers, with payment updates and new deadlines kicking in early next year.
Previous / Next Documents
Previous: 2026-01807 — Notice of Availability and Request for Comment: Revision to the Voluntary Standard for Infant and Cradle Swings
The Consumer Product Safety Commission wants your thoughts on updates to the safety rules for infant and cradle swings. These changes could make swings safer for babies and affect manufacturers and parents. You’ve got until February 12, 2026, to share your opinion—no cost changes announced yet, just safer swings ahead!
Next: 2026-01833 — Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates the rules for Organ Procurement Organizations (OPOs) that help collect and share organs for transplants. It adds clearer guidelines, new quality checks, and updates how OPOs compete and appeal decisions to boost organ donations and save more lives. OPOs and transplant patients will feel the impact, with comments open until March 31, 2026, and no new costs announced yet.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in